Application of DNA Microarrays in Pharmacogenomics and Toxicogenomics

Keywords

Toxicogenomics, Pharmacogenomics, Xenobiotic, DNA microarray, Biology

References

• Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.Kazuya Kudoh, Manasi Ramanna, Roald Ravatn — 2000
• Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.Thomas H. Rushmore, A.-N. Tony Kong — 2002
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA MicroarrayMark Schena, Dari Shalon, Ronald W. Davis — 1995
• Isolation of cDNA encoding the human NF-E2 protein.Julia Y. Chan, Xiaosong Han, Y Kan — 1993
• Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.Venugopal Radjendirane, Anil K. Jaiswal — 1996
• Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2.H.-C. Huang, Truyen Nguyen, Cecil B. Pickett — 2000
• The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells.Susan J. Duthie, M.H. Grant — 1989
• Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast.Julia Y. Chan, Xiaosong Han, Yuet Wai Kan — 1993
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.Andreas Rosenwald, George W. Wright, Wing C. Chan — 2002
• Number of CpG islands and genes in human and mouse.Francisco Antequera, Adrian Bird — 1993
• Gene-expression profiles predict survival of patients with lung adenocarcinomaDavid G. Beer, Sharon L. R. Kardia, Chiang‐Ching Huang — 2002
• Signal transduction events elicited by cancer prevention compounds.Ah‐Ng Tony Kong, Rong Yu, Vidya Hebbar — 2001
• High density synthetic oligonucleotide arraysRobert J. Lipshutz, Stephen P. A. Fodor, T Gingeras — 1999
• Activation of Mitogen-activated Protein Kinase Pathways Induces Antioxidant Response Element-mediated Gene Expression via a Nrf2-dependent Mechanism*Rong Yu, Chi Chen, Yin-Yuan Mo — 2000
• Induction of xenobiotic enzymes by the map kinase pathway and the antioxidant or electrophile response element (ARE/EpRE),†,‡Angela Kong, Edward D. Owuor, Rong Yu — 2001
• Phosphatidylinositol 3-Kinase, Not Extracellular Signal-regulated Kinase, Regulates Activation of the Antioxidant-Responsive Element in IMR-32 Human Neuroblastoma Cells*Jong‐Min Lee, Janean M. Hanson, Waihei A. Chu — 2001
• 26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes*Yong Mao, Shyamal D. Desai, Chun‐Yuan Ting — 2001
• hMAF, a Small Human Transcription Factor That Heterodimerizes Specifically with Nrf1 and Nrf2*M. Marini, Kaimin Chan, Letizia Casula — 1997
• Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis.Xi Zheng — 2002
• Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation.Cynthia A. Afshari, Emile F. Nuwaysir, J. Carl Barrett — 1999

Cited by

• RNA and DNA microarrays.Stuart C. Sealfon, Tearina Chu — 2011
• New Strategies in Drug DiscoveryEliot H. Ohlstein, Anthony G. Johnson, John D. Elliott — 2006
• Variability of DNA Microarray Gene Expression Profiles in Cultured Rat Primary HepatocytesJun Xu, Xutao Deng, Victor Chan — 2007
• Designing Toxicogenomics Studies that use DNA Array TechnologyRobert R. Delongchamp, Cruz Velasco, Varsha G. Desai — 2008
• Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray.Yick Fu Wong, Zachariah Selvanayagam, Nien Wei — 2003
• Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers.Zhi-Qiang Jiang, Chi Chen, Bo Yang — 2003
• Spectroscopic characterization of fluorescein- and tetramethylrhodamine-labeled oligonucleotides and their complexes with a DNA template.L. Wang, Adolfas K. Gaigalas, Joseph Blasic — 2004
• Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics.Claude E. Gagna, W. Clark Lambert — 2009
• Analysis of host response to bacterial infection using error model based gene expression microarray experimentsDov J. Stekel — 2005
• Application of DNA Microarrays in Occupational Health ResearchShinji Koizumi — 2004
• Emerging technologies and challenges for better and safer drugsMaria Theodosiou, Arsia Amir-Aslani, Bruno Mégarbane — 2014
• Application of toxicogenomic tools in the drug research and development process.Nicolas Fabre, Isolde Anglade, Joan Albert Vericat — 2009
• DNA microarrays and pharmacogenomics.Rolando Meloni — 2004
• Molecular approaches to the identification of biomarkers of exposure and effect--report of an expert meeting organized by COST Action B15. November 28, 2003.Ursula Gundert‐Remy, Svein G. Dahl, Alan R. Boobis — 2005
• cDNA Microarrays – Providing Insight into Organism/Chemotherapeutic InteractionsElisé P. Wright — 2010
• Gene Expression Signature and the Prediction of Lymph Node Metastasis in Colorectal Cancer by DNA MicroarrayToshiaki Watanabe, Takashi Kobunai, Toshiaki Tanaka — 2009
• Advances in pharmacogenomic research and developmentJeanette McCarthy — 2003
• The Use of Toxicogenomic Data in Risk Assessment: A Regulatory PerspectiveVivian S. W. Chan, Mette Due Theilade — 2005
• Microarray technology--an intellectual property retrospective.Richard Rouse, Gary Hardiman — 2003
• Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays.Anu Sharma, Vineet K. Sharma, Shirley Horn‐Saban — 2005

Related papers

• The utility of DNA microarrays for characterizing genotoxicity.Ronald K. Newton, Marilyn J. Aardema, Jiri Aubrecht — 2004
• DNA microarrays and toxicogenomics: applications for ecotoxicology?Norman F. Neumann, Fernando Gálvez — 2002
• Toxicogenomics and applications of DNA microarraysJia Cao, Ziyuan Zhou, Fude Fang — 2000
• Microarrays and toxicology: The advent of toxicogenomicsEmile F. Nuwaysir, M. Bittner, Jeffrey M. Trent — 1999
• Toxicogenomics and applications of DNA microarraysZhou Zi — 2000
• Toxicogenomics using yeast DNA microarrays.Daisuke Yasokawa, Hitoshi Iwahashi — 2010
• Pharmacogenomics to Revive Drug Development in Cardiovascular DiseaseMarie‐Pierre Dubé, Simon de Denus, Jean‐Claude Tardif — 2016
• Implications of pharmacogenomics for drug development.R. J. Kirk, Jui‐Hsiang Hung, Steve Horner — 2008